112 related articles for article (PubMed ID: 7865315)
1. Interest in HIV vaccines among injection drug users in Baltimore, Maryland.
Vlahov D; Astemborski J; Solomon L; Galai N; Basarab L; Nelson KE
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S265-8. PubMed ID: 7865315
[TBL] [Abstract][Full Text] [Related]
2. Preparations for AIDS vaccine trials. Incident human immunodeficiency virus (HIV) infections in a cohort of injection drug users in Baltimore, Maryland.
Nelson KE; Vlahov D; Galai N; Astemborski J; Solomon L
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S201-5. PubMed ID: 7865301
[TBL] [Abstract][Full Text] [Related]
3. Preparations for AIDS vaccine trials. Recruitment and retention of in- and out-of-treatment injection drug users.
Woody GE; Metzger D; Mulvaney F
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S197-9. PubMed ID: 7865300
[No Abstract] [Full Text] [Related]
4. Will preventive HIV vaccine efficacy trials be possible with female injection drug users?
Meyers K; Metzger DS; McLellan AT; Navaline H; Sheon AR; Woody GE
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(5):577-85. PubMed ID: 8548338
[TBL] [Abstract][Full Text] [Related]
5. Changes in willingness to participate in HIV vaccine trials among HIV-negative injection drug users.
Golub ET; Purvis LA; Sapun M; Safaeian M; Beyrer C; Vlahov D; Strathdee SA
AIDS Behav; 2005 Sep; 9(3):301-9. PubMed ID: 16088366
[TBL] [Abstract][Full Text] [Related]
6. Interest in HIV vaccines among Italian injection drug users. The Network Interregionale SERT.
Serpelloni G; Vlahov D; Mazzi M; Rezza G
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Oct; 10(2):206-7. PubMed ID: 7552488
[No Abstract] [Full Text] [Related]
7. Participation in clinical trials among women living with HIV in Canada. Canadian Women's HIV Study Group.
Hankins C; Lapointe N; Walmsley S
CMAJ; 1998 Dec; 159(11):1359-65. PubMed ID: 9861204
[TBL] [Abstract][Full Text] [Related]
8. Behavioral research contributions to planning and conducting HIV vaccine efficacy studies.
Temoshok LR
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S277-80. PubMed ID: 7865318
[No Abstract] [Full Text] [Related]
9. Medical eligibility, comprehension of the consent process, and retention of injection drug users recruited for an HIV vaccine trial.
Harrison K; Vlahov D; Jones K; Charron K; Clements ML
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Nov; 10(3):386-90. PubMed ID: 7552502
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a video-supplement to informed consent: injection drug users and preventive HIV vaccine efficacy trials.
Fureman I; Meyers K; McLellan AT; Metzger D; Woody G
AIDS Educ Prev; 1997 Aug; 9(4):330-41. PubMed ID: 9376207
[TBL] [Abstract][Full Text] [Related]
11. Risk behaviours and comprehension among intravenous drug users volunteered for HIV vaccine trial.
Pitisuttithum P; Migasena S; Laothai A; Suntharasamai P; Kumpong C; Vanichseni S
J Med Assoc Thai; 1997 Jan; 80(1):47-50. PubMed ID: 9078816
[TBL] [Abstract][Full Text] [Related]
12. Preparations for AIDS vaccine trials. Developing brief valid screening instruments for HIV-related sexual risk behavior among gay and bisexual men.
McKirnan DJ; Doetsch J; Vanable P; Buchbinder S; Douglas JM; Judson F
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S285-8. PubMed ID: 7865320
[TBL] [Abstract][Full Text] [Related]
13. The decision to enroll in HIV vaccine efficacy trials: concerns elicited from gay men at increased risk for HIV infection.
MacQueen KM; Buchbinder S; Douglas JM; Judson FN; McKirnan DJ; Bartholow B
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S261-4. PubMed ID: 7865314
[No Abstract] [Full Text] [Related]
14. Global HIV cohort studies among injecting drug users and future vaccine trials.
Woratanarat T
J Med Assoc Thai; 2006 Jul; 89(7):1064-79. PubMed ID: 16881444
[TBL] [Abstract][Full Text] [Related]
15. Preparations for AIDS vaccine trials. An automated version of the Risk Assessment Battery (RAB): enhancing the assessment of risk behaviors.
Navaline HA; Snider EC; Petro CJ; Tobin D; Metzger D; Alterman AI; Woody GE
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S281-3. PubMed ID: 7865319
[TBL] [Abstract][Full Text] [Related]
16. Behavioral studies relevant to vaccine trial preparation: an introduction.
Turner CF; Sheon AR
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S273-6. PubMed ID: 7865317
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with incarceration and incident human immunodeficiency virus (HIV) infection among injection drug users participating in an HIV vaccine trial in Bangkok, Thailand, 1999-2003.
Suntharasamai P; Martin M; Vanichseni S; van Griensven F; Mock PA; Pitisuttithum P; Tappero JW; Sangkum U; Kitayaporn D; Gurwith M; Choopanya K;
Addiction; 2009 Feb; 104(2):235-42. PubMed ID: 19149819
[TBL] [Abstract][Full Text] [Related]
18. HIV vaccines for injection drug users in the context of a comprehensive prevention agenda.
Vlahov D
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S3-6. PubMed ID: 7865324
[TBL] [Abstract][Full Text] [Related]
19. Willingness to participate in HIV vaccine trials among HIV-negative gay men in Sydney, Australia.
Van de Ven P; Mao L; Crawford J; Prestage G; Grulich A; Kaldor J; Kippax S
Int J STD AIDS; 2005 Apr; 16(4):314-7. PubMed ID: 15899086
[TBL] [Abstract][Full Text] [Related]
20. Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand.
Pitisuttithum P; Gilbert P; Gurwith M; Heyward W; Martin M; van Griensven F; Hu D; Tappero JW; Choopanya K;
J Infect Dis; 2006 Dec; 194(12):1661-71. PubMed ID: 17109337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]